Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Parkinsonian Brain Repair Using Human Stem Cells
Phase 1
- Conditions
- Idiopathic Parkinson Disease
- Interventions
- Drug: Human Stem Cells
- First Posted Date
- 2016-05-24
- Last Posted Date
- 2016-06-13
- Lead Sponsor
- Celavie Bioscences, LLC
- Target Recruit Count
- 8
- Registration Number
- NCT02780895
- Locations
- 🇲🇽
Hospital Angeles del Pedregal, Mexico City, Mexico
News
No news found